Penserra Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$72.34 - $95.09 $27,489 - $36,134
-380 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$97.2 - $137.59 $1,458 - $2,063
15 Added 4.11%
380 $37,000
Q1 2021

May 13, 2021
BUY
$108.54 - $125.2 $542 - $626
5 Added 1.39%
365 $42,000
Q4 2020

Feb 12, 2021
BUY
$110.06 - $133.7 $39,621 - $48,131
360 New
360 $40,000

Others Institutions Holding MDGL

# of Institutions
298
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.24B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email